After showing signs of recovery in June, domestic pharma sales dip in July

Data shows that the Covid-19 crisis impacted the growth rate of the domestic market

The domestic pharmaceutical industry clocked negligible growth of 0.2 per cent in July after showing signs of recovery in June. Most therapy areas posted a drop in sales growth rate. Growth has been under pressure since the lockdowns related to Covid-19 started and fresh prescription generations slowed. In May, the Indian pharma market contracted 9 per cent after declining 11 per cent in April. June, however, saw some recovery with the growth coming back at 2.4 per cent.

According to the data from market research firm AIOCD AWACS, the Covid-19 pandemic impacted the growth rate of the domestic market. However, some